Home The Word Brain	My Amedeo FAQ Privacy About
	As of October 2023, Amedeo had 12,263 active subscribers

Chronic Renal Failure

Free Subscription Articles published in Nephron Retrieve available abstracts of 66 articles: HTML format

Single Articles

November 2023
1. JEON YH, Lee SW, Jeon Y, Cho JH, et al
   The impact of C-reactive protein-to-albumin ratio on mortality in patients with acute kidney injury requiring continuous renal replacement therapy: A multicenter retrospective study.
   Nephron. 2023 Nov 29. doi: 10.1159/000534970.
   PubMed     Abstract available
   
   
   
2. YILMAZ S, Ozcakar ZB, Cakar N, Biral Coskun B, et al
   HOSPITALIZATIONS AFTER RENAL TRANSPLANTATION IN CHILDREN: RISK FACTORS, CAUSES AND OUTCOMES.
   Nephron. 2023 Nov 2. doi: 10.1159/000534787.
   PubMed     Abstract available
   
   
   October 2023
3. YAN Z, Shao T
   Chronic Inflammation in Chronic Kidney Disease.
   Nephron. 2023 Oct 18. doi: 10.1159/000534447.
   PubMed     Abstract available
   
   
   
4. HABERAL G, Yildirim T, Yilmaz SR, Altun B, et al
   CHRONIC KIDNEY DISEASE RISK IN LIVING KIDNEY TRANSPLANT DONORS: A LONG-TERM FOLLOW-UP STUDY.
   Nephron. 2023 Oct 3. doi: 10.1159/000534397.
   PubMed     Abstract available
   
   
   September 2023
5. YING M, Shao X, Qin H, Yin P, et al
   Disease burden and epidemiological trends of chronic kidney disease at the global, regional, national levels from 1990 to 2019.
   Nephron. 2023 Sep 15. doi: 10.1159/000534071.
   PubMed     Abstract available
   
   
   
6. NOWICKI M, Drozdz M, Wajda J, Klatko W, et al
   Continuous erythropoietin receptor activator for the treatment of chronic dialysis patients with renal anemia in daily clinical practice in Poland: A non-interventional, multi-center, pragmatic NAVIGO trial.
   Nephron. 2023 Sep 14. doi: 10.1159/000534070.
   PubMed     Abstract available
   
   
   
7. ZHANG Z, Liu P, Yang L, Zhao N, et al
   Association between the high-sensitivity C-reactive protein/albumin ratio on new-onset chronic kidney disease in Chinese individuals.
   Nephron. 2023 Sep 12. doi: 10.1159/000534034.
   PubMed     Abstract available
   
   
   August 2023
8. LUMLERTGUL N, Cameron LK, Bear DE, Ostermann M, et al
   Micronutrient Losses during Continuous Renal Replacement Therapy.
   Nephron. 2023 Aug 23:1-7. doi: 10.1159/000531947.
   PubMed     Abstract available
   
   
   
9. MORALES FEBLES R, Marrero Miranda D, Cruz Perera CC, Diaz Martin L, et al
   Therapeutic exercise on metabolic and renal outcomes in patients with Chronic Kidney Disease (CKD): A narrative review.
   Nephron. 2023 Aug 23. doi: 10.1159/000531921.
   PubMed     Abstract available
   
   
   
10. YOSHIKOSHI S, Yamamoto S, Suzuki Y, Imamura K, et al
    Association Between Physical Frailty and Sleep Disturbances Among Patients on Hemodialysis: A Cross-sectional Study.
    Nephron. 2023 Aug 16. doi: 10.1159/000533418.
    PubMed     Abstract available
    
    
    
11. ADRIAN T, Hornum M, Knop FK, Christensen KB, et al
    Hepatic Fibrosis Evaluated in Patients with Type 2 Diabetes with and without Chronic Kidney Disease.
    Nephron. 2023 Aug 16:1-12. doi: 10.1159/000531574.
    PubMed     Abstract available
    
    
    
12. HARA S
    The Chronology of Renal Allograft Dysfunction: The Pathological Perspectives.
    Nephron. 2023 Aug 11:1-7. doi: 10.1159/000531575.
    PubMed     Abstract available
    
    
    July 2023
13. LIU J, Zuo L, Walpen S, Bernard L, et al
    Efficacy and safety of sucroferric oxyhydroxide compared with sevelamer carbonate in Chinese dialysis patients with hyperphosphataemia: A randomised, open-label, multicentre, 12-week phase III study.
    Nephron. 2023 Jul 20:1. doi: 10.1159/000531869.
    PubMed     Abstract available
    
    
    
14. PIKO N, Bevc S, Hojs R, Ekart R, et al
    Atherosclerosis and Epigenetic Modifications in Chronic Kidney Disease.
    Nephron. 2023 Jul 17:1-5. doi: 10.1159/000531292.
    PubMed     Abstract available
    
    
    
15. MILAN MANANI S, Mattiotti M, Marcello M, VIRZi GM, et al
    Contrast Induced Encephalopathy: a rare complication in a patient on Peritoneal Dialysis with several risk factors.
    Nephron. 2023 Jul 13. doi: 10.1159/000531771.
    PubMed     Abstract available
    
    
    
16. LIU J, Purtell L, Bonner A
    Kidney supportive care for working age adults with chronic kidney disease: A profile of characteristics and symptom burden.
    Nephron. 2023 Jul 10. doi: 10.1159/000531872.
    PubMed     Abstract available
    
    
    June 2023
17. HOJS R, Ekart R, Bevc S, Vodosek Hojs N, et al
    Chronic kidney disease and obesity.
    Nephron. 2023 Jun 2. doi: 10.1159/000531379.
    PubMed     Abstract available
    
    
    May 2023
18. FRAGALE G, Laham G, Raffaele P, Fortunato M, et al
    Renal transplantation in the elderly. Are they all the same? A multicenter, comorbidity based study.
    Nephron. 2023 May 25. doi: 10.1159/000531178.
    PubMed     Abstract available
    
    
    
19. JAMALE T, Kulkarni M, Keskar V
    What's wrong with the blood pressure target recommendation of KDIGO 2021 for hypertension in chronic kidney disease?
    Nephron. 2023 May 25. doi: 10.1159/000531029.
    PubMed     Abstract available
    
    
    
20. SHIMIZU T, Omoto K, Inui M, Nozaki T, et al
    Clinicopathological analyses of chronic renal allograft arteriopathy after kidney transplantation.
    Nephron. 2023 May 25. doi: 10.1159/000531177.
    PubMed     Abstract available
    
    
    
21. SAKA Y, Naruse T, Chikamatsu T, Mitani K, et al
    Long-term proton pump inhibitor therapy increases the risk of infection in patients with incident hemodialysis.
    Nephron. 2023 May 17:1. doi: 10.1159/000531028.
    PubMed     Abstract available
    
    
    
22. SANDOKJI I, Xu Y, Denburg M, Furth S, et al
    Current and Novel Biomarkers of Progression Risk in Children with Chronic Kidney Disease.
    Nephron. 2023 May 15:1. doi: 10.1159/000530918.
    PubMed     Abstract available
    
    
    March 2023
23. BERNER T, Ferro C, Dieguez G, Metz S, et al
    Real-World Phosphate Binder Use Among Dialysis-Dependent Patients With CKD.
    Nephron. 2023 Mar 30. doi: 10.1159/000530230.
    PubMed     Abstract available
    
    
    
24. UZZO M, Moroni G, Ponticelli C
    Thin Basement Membrane: An Underrated Cause of End-Stage Renal Disease.
    Nephron. 2023 Mar 7:1-9. doi: 10.1159/000528243.
    PubMed     Abstract available
    
    
    February 2023
25. PREMARATHNE SS, Gamage C, Chandrajith R, Ratnatunge NV, et al
    Leptospirosis: A Potential Culprit for Chronic Kidney Disease of Uncertain Etiology.
    Nephron. 2023 Feb 21:1-10. doi: 10.1159/000528703.
    PubMed     Abstract available
    
    
    
26. KOBAYASHI A, Takeda A, Shinjo H, Iguchi D, et al
    Light chain deposition disease recurrence in renal allograft after long-term remission.
    Nephron. 2023 Feb 21. doi: 10.1159/000529776.
    PubMed     Abstract available
    
    
    January 2023
27. CHOU YH, Lai TS, Lin YC, Chiang WC, et al
    Age-Dependent Effects of Acute Kidney Injury on End-Stage Kidney Disease and Mortality in Patients with Moderate to Severe Chronic Kidney Disease.
    Nephron. 2023 Jan 17:1-8. doi: 10.1159/000528021.
    PubMed     Abstract available
    
    
    
28. ADRIAN T, Hornum M, Knop FK, Almdal T, et al
    Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes and Chronic Kidney Disease.
    Nephron. 2023 Jan 11:1-12. doi: 10.1159/000528080.
    PubMed     Abstract available
    
    
    
29. MIRIOGLU S, Kazancioglu R, Cebeci E, Eren N, et al
    Humoral Response to BNT162b2 and CoronaVac in Patients Undergoing Maintenance Hemodialysis: A Multicenter Prospective Cohort Study.
    Nephron. 2023 Jan 5:1-9. doi: 10.1159/000528170.
    PubMed     Abstract available
    
    
    
30. RHEE CM, You AS, Page V, Hayashida G, et al
    Racial and Ethnic Differences in Chronic Kidney Disease and Its Risk Factors among Asian-Americans and Pacific Islanders in Hawaii.
    Nephron. 2023 Jan 5:1-10. doi: 10.1159/000527990.
    PubMed     Abstract available
    
    
    
31. RODRIGUEZ-ESPINOSA D, Broseta JJ, Bastida C, Alvarez-Mora MI, et al
    Creatine Kinase Elevation in Autosomal Dominant Polycystic Kidney Disease Patients on Tolvaptan Treatment.
    Nephron. 2023;147.
    PubMed     Abstract available
    
    
    
32. TREVISANI F, Floris M, Cinque A, Bettiga A, et al
    Renal Histology in CKD Stages: Match or Mismatch with Glomerular Filtration Rate?
    Nephron. 2023;147:266-271.
    PubMed     Abstract available
    
    
    
33. GUO H, Bechtel-Walz W
    The Interplay of Autophagy and Oxidative Stress in the Kidney: What Do We Know?
    Nephron. 2023;147:627-642.
    PubMed     Abstract available
    
    
    
34. NONOYAMA S, Hotta K, Iwahara N, Tanabe T, et al
    Use of Mixed Lymphocyte Reaction Assay to Evaluate Immune Tolerance before Kidney Transplantation with an Immunosuppression-Free Protocol following Hematopoietic Stem Cell Transplantation from the Same Donor.
    Nephron. 2023;147:621-626.
    PubMed     Abstract available
    
    
    
35. ZHU M, Jiang L, Xu F, Hu J, et al
    Clinicopathological Characteristics and Outcomes of Renal Sarcoidosis: A Series Study of 18 Patients from a Single Center.
    Nephron. 2023;147:591-598.
    PubMed     Abstract available
    
    
    
36. KAWABE M, Yamamoto I
    Current Status and Perspectives on Recurrent IgA Nephropathy after Kidney Transplantation.
    Nephron. 2023;147 Suppl 1:9-13.
    PubMed     Abstract available
    
    
    November 2022
37. ZHAN Q, Zhao J, Guo Q, Niu J, et al
    Association of Sleep Duration with Physical Performance in Hemodialysis Patients: A Multicenter Cross-Sectional Study.
    Nephron. 2022 Nov 29:1-6. doi: 10.1159/000527406.
    PubMed     Abstract available
    
    
    October 2022
38. SENZAKI D, Yoshioka N, Nagakawa O, Inayama E, et al
    Modeling Low Muscle Mass Screening in Hemodialysis Patients.
    Nephron. 2022 Oct 21:1-9. doi: 10.1159/000526866.
    PubMed     Abstract available
    
    
    September 2022
39. OZTURK S, Gursu M, Arici M, Sahin I, et al
    Evaluation of Outcomes of Peritoneal Dialysis Patients in the Post-COVID-19 Period: A National Multicenter Case-Control Study from Turkey.
    Nephron. 2022 Sep 30:1-9. doi: 10.1159/000526234.
    PubMed     Abstract available
    
    
    
40. KIMURA H, Yoshida S, Takeuchi M, Kawakami K, et al
    Impact of Potentially Inappropriate Medications on Kidney Function in Chronic Kidney Disease: Retrospective Cohort Study.
    Nephron. 2022 Sep 16:1-8. doi: 10.1159/000526326.
    PubMed     Abstract available
    
    
    July 2022
41. AGUR T, Zingerman B, Ben-Dor N, Alkeesh W, et al
    Humoral Response to the Third Dose of BNT162b2 COVID-19 Vaccine among Hemodialysis Patients.
    Nephron. 2022 Jul 27:1-8. doi: 10.1159/000525519.
    PubMed     Abstract available
    
    
    
42. CHARITAKI E, Damianakis N, Garbidaki A, Stamataki E, et al
    DPP4 Inhibitor-Induced Bullous Pemphigoid in Patients with Diabetes and Chronic Kidney Disease: Clinical Case Series.
    Nephron. 2022 Jul 18:1-6. doi: 10.1159/000525520.
    PubMed     Abstract available
    
    
    
43. BOMHOLT T, Kofod D, Norgaard K, Rossing P, et al
    Can the Use of Continuous Glucose Monitoring Improve Glycemic Control in Patients with Type 1 and 2 Diabetes Receiving Dialysis?
    Nephron. 2022 Jul 13:1-6. doi: 10.1159/000525676.
    PubMed     Abstract available
    
    
    May 2022
44. MURT A, Dinc HO, Altiparmak MR, Yalin SF, et al
    Waning of SARS-CoV-2 Vaccine-Induced Immune Response over 6 Months in Peritoneal Dialysis Patients and the Role of a Booster Dose in Maintaining Seropositivity.
    Nephron. 2022 May 20:1-5. doi: 10.1159/000524658.
    PubMed     Abstract available
    
    
    April 2022
45. GUINAULT D, Bernier M, Delarche A, Neuville S, et al
    Immunogenicity of the BNT162b2 Vaccine in Patients Undergoing Maintenance Hemodialysis Is Associated with Medical Conditions.
    Nephron. 2022 Apr 27:1-6. doi: 10.1159/000524292.
    PubMed     Abstract available
    
    
    
46. ASH SR, Batlle D, Kendrick J, Oluwatosin Y, et al
    Effect of Sodium Zirconium Cyclosilicate on Serum Potassium and Bicarbonate in Patients with Hyperkalemia and Metabolic Acidosis Associated with Chronic Kidney Disease: Rationale and Design of the NEUTRALIZE Study.
    Nephron. 2022 Apr 22:1-11. doi: 10.1159/000523911.
    PubMed     Abstract available
    
    
    March 2022
47. KONN V, Motrapu M, Swiderska MK, Anders HJ, et al
    Drug Testing for Chronic Kidney Disease and Diabetes in Animals versus Humans: A Comparative Analysis of Study Designs and Reporting Qualities.
    Nephron. 2022 Mar 23:1-11. doi: 10.1159/000523666.
    PubMed     Abstract available
    
    
    February 2022
48. TODA A, Hara S, Tsuji H, Arase Y, et al
    Effects of Body Weight Change on Development of Chronic Kidney Disease in Obese Metabolic Phenotypes.
    Nephron. 2022 Feb 18:1-8. doi: 10.1159/000522159.
    PubMed     Abstract available
    
    
    
49. HAKAMAKI M, Jarvisalo MJ, Lankinen R, Koivuviita N, et al
    Evolution of Quality of Life in Chronic Kidney Disease Stage 4-5 Patients Transitioning to Dialysis and Transplantation.
    Nephron. 2022 Feb 9:1-10. doi: 10.1159/000521771.
    PubMed     Abstract available
    
    
    
50. SY J, Wenziger C, Marroquin M, Kalantar-Zadeh K, et al
    Warfarin Use, Stroke, and Bleeding Risk among Pre-Existing Atrial Fibrillation US Veterans Transitioning to Dialysis.
    Nephron. 2022 Feb 4:1-9. doi: 10.1159/000521494.
    PubMed     Abstract available
    
    
    January 2022
51. KIDA N, Morishima T, Tsubakihara Y, Miyashiro I, et al
    Stage at Diagnosis and Prognosis of Colorectal, Stomach, Lung, Liver, Kidney, and Bladder Cancers in Dialysis Patients: A Multicenter Retrospective Study Using Cancer Registry Data and Administrative Data.
    Nephron. 2022 Jan 28:1-10. doi: 10.1159/000521603.
    PubMed     Abstract available
    
    
    
52. LEI Q, Xu F, Liang S, Liang D, et al
    Clinical Acute Kidney Injury and Histologic Acute Tubular-Interstitial Injury and Their Prognosis in Diabetic Nephropathy.
    Nephron. 2022;146:351-359.
    PubMed     Abstract available
    
    
    
53. JUNG J, Lee JH, Park YS
    Therapeutic Response and Long-Term Renal Outcomes in Childhood Idiopathic Steroid-Resistant Nephrotic Syndrome: A Single-Center Study.
    Nephron. 2022;146:327-334.
    PubMed     Abstract available
    
    
    
54. SOOHOO M, Hashemi L, Hsiung JT, Moradi H, et al
    Association of Serum Triglycerides and Renal Outcomes among 1.6 Million US Veterans.
    Nephron. 2022;146:457-468.
    PubMed     Abstract available
    
    
    December 2021
55. OUYANG J, Bajracharya S, John S, Wagner J, et al
    Clotting of Hemodialysis Access in Patients with COVID-19 in an Inner-City Hospital.
    Nephron. 2021 Dec 20:1-6. doi: 10.1159/000520174.
    PubMed     Abstract available
    
    
    November 2021
56. PETNAK T, Thongprayoon C, Cheungpasitporn W, Shawwa K, et al
    The Prognostic Importance of Serum Sodium for Mortality among Critically Ill Patients Requiring Continuous Renal Replacement Therapy.
    Nephron. 2021 Nov 18:1-7. doi: 10.1159/000519686.
    PubMed     Abstract available
    
    
    
57. DONG X, Cao R, Li Q, Yin L, et al
    The Long Noncoding RNA-H19 Mediates the Progression of Fibrosis from Acute Kidney Injury to Chronic Kidney Disease by Regulating the miR-196a/Wnt/beta-Catenin Signaling.
    Nephron. 2021 Nov 17:1-11. doi: 10.1159/000518756.
    PubMed     Abstract available
    
    
    
58. BOMHOLT T, Feldt-Rasmussen B, Butt R, Borg R, et al
    Hemoglobin A1c and Fructosamine Evaluated in Patients with Type 2 Diabetes Receiving Peritoneal Dialysis Using Long-Term Continuous Glucose Monitoring.
    Nephron. 2021 Nov 3:1-7. doi: 10.1159/000519493.
    PubMed     Abstract available
    
    
    October 2021
59. BROGAN M, Ross MJ
    The Impact of Chronic Kidney Disease on Outcomes of Patients with COVID-19 Admitted to the Intensive Care Unit.
    Nephron. 2021 Oct 11:1-5. doi: 10.1159/000519530.
    PubMed     Abstract available
    
    
    January 2021
60. HAKAMAKI M, Hellman T, Lankinen R, Koivuviita N, et al
    Elevated Troponin T and Enlarged Left Atrium Are Associated with the Incidence of Atrial Fibrillation in Patients with CKD Stage 4-5.
    Nephron. 2021;145:71-77.
    PubMed     Abstract available
    
    
    
61. DE VRIES BCS, Berger SP, Bakker SJL, de Borst MH, et al
    Pre-Transplant Plasma Potassium as a Potential Risk Factor for the Need of Early Hyperkalaemia Treatment after Kidney Transplantation: A Cohort Study.
    Nephron. 2021;145:63-70.
    PubMed     Abstract available
    
    
    
62. MORALES E, Galindo M, Trujillo H, Praga M, et al
    Update on Lupus Nephritis: Looking for a New Vision.
    Nephron. 2021;145:1-13.
    PubMed     Abstract available
    
    
    
63. MASAJTIS-ZAGAJEWSKA A, Pawlowicz E, Nowicki M
    Effect of Short-Term Cold Exposure on Central Aortic Blood Pressure in Patients with CKD.
    Nephron. 2021;145:20-26.
    PubMed     Abstract available
    
    
    
64. MOHAMMED A, Marie MA, Abdulazim DO, Hassan M, et al
    Serum Urate Lowering Therapy Using Allopurinol Improves Serum 25 Hydroxy Vitamin D in Stage 3-5 CKD Patients: A Pilot Study.
    Nephron. 2021;145:133-136.
    PubMed     Abstract available
    
    
    
65. KAIMORI JY, Mori T, Namba-Hamano T, Morimoto T, et al
    Cyclosporine A Treatment of Proteinuria in a New Case of MAFB-Associated Glomerulopathy without Extrarenal Involvement: A Case Report.
    Nephron. 2021;145:445-450.
    PubMed     Abstract available
    
    
    
66. KALANTAR-ZADEH K, Li PK, Tantisattamo E, Kumaraswami L, et al
    Living Well with Kidney Disease by Patient and Care-Partner Empowerment: Kidney Health for Everyone Everywhere.
    Nephron. 2021;145:205-211.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Chronic Renal Failure is free of charge.